Navigation Links
Kidz-Med Inc. Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season
Date:9/8/2009

ting the success to PR, social media and SEO/SEM tactics which enabled people to find them as a go-to resource. The Company attributes the week's success to the same efforts.

The Kidz-Med Thermofocus, which was used by medical personnel in Asia during the SARS epidemic (See BBC article: http://news.bbc.co.uk/2/hi/business/2986469.stm), is an ideal instrument to use to diagnose fevers associated with the flu since it has absolutely no contact with the skin, making for a completely hygienic and non-invasive experience; a reading is taken in a second and the thermometer is clinically proven to be accurate and safe.

About Kidz-Med, Inc.

A division of American Scientific Resources, Inc., Kidz-Med, Inc., was founded in 1993 by Dr. Christopher F. Tirotta to create children's pre-operative educational videos "A Hospital Trip With Dr. Bip" and "Dr. Bip's New Baby Tips". Today, Kidz-Med, Inc. is leading the pediatric and children's health and safety products industry in innovation by providing the most revolutionary patented family-friendly products sourced from around the globe to help keep children safe and parents reassured. For additional information, visit www.kidzmed.com or www.americansci.com.

Safe Harbor

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this
'/>"/>

SOURCE Kidz-Med Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Kidz-Med to Launch the Thermofocus(R) 5-in-1 Exclusively at Walgreens Stores Nationwide
2. The Doctors Diagnose the Kidz-Med Thermofocus
3. Parents Day is Coming - Kidz-Med Celebrates the Role of Parents
4. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
5. DaVita Receives Civil Complaint
6. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
7. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
8. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
9. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
10. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
11. Temple Emergency Medicine receives $1.8M to find best MRSA treatment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmo...Butachiropractorcanalsogivepatientsthehelptheyneed...ereyourjaw(mandible)contacts/connectswithyourskull...tedwithTMJdysfunctionarepainwithchewing,clickingor...mTMJdysfunctionincluding:headaches,fatigue,sleepdi...
(Date:11/25/2009)... TORONTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,...ualizationsoftwarelaunchesasuiteofnewleadingedgecl...wareplatformatthisyear,sRadiologicalSocietyofNorth...009(Booth5800,HallA).Theapplicationsleveragetheuni...izedMRIimagingcoilsandsupportmultipleimagingmodali...
(Date:11/25/2009)... SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQua...nter Spare the Air Alert forThursday...irelogsoranyothersolidfuel,bothindoorsandoutdoors....airqualitytomorrow,"saidJackBroadbent,executiveoff...orespectthehealthoftheirneighborsandfellowcommunit...
(Date:11/25/2009)...ortuitous discovery that grew out of a collaborati...entially offer hope to the nearly 10 million Ameri... , Also known as hardening of the arteries, p...rculatory problem in which narrowed arteries reduc...ered a red flag for vascular disease, heart attack...
(Date:11/25/2009)... Evaluation and treatment clinic... Woodstock (Vocus) November 25, 2009 -- Centeg... vaccines and H1N1 vaccine shots at four Centegra ...er shipment of vaccine has arrived. The clinics ar... and McHenry and will be open as follows: , &n...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...wn to have a genetic predisposition. //This study ... DNA double helix. Collaborated Research is b...de Hospital campus of The Feinstein Institute for ... that vary dramatically in symptoms and severity a...
...greement to deliver a fast, efficient new electron...ve as a win for patients and doctors alike. T...irst organisation to sign up to deliver the new sy...mmittee on Information Technology, Dr Peter Garcia...
...and disappointment on hearing the news about a Lib...ences on five Bulgarian nurses and one Palestinian...reds of children with HIV. George Bush has exp...urses would be fully supported by him. The US ...
...IDF) Diabetes Atlas released early December in Sou...hest in India.// But China overtakes India in the ...T). The Atlas, third in a series that began i... is predicted to increase dramatically over the ne...
...read to many different sites often do not have man...to tolerate the doses of treatment they would need... Hope and St. Jude Children's Research Hospital ma...trate chemotherapeutic drugs predominately at tumo...
... research centre is being planned at the Pune-base...eat diseases//, a general says. "Stem cell ther...edicine. It will be the futuristic treatment repla...e disease and various other diseases can be cured,...
Other Medicine News:Health News:Research on Bipolar Disorder Launched 2Health News:Researchers Find Stem-cell Therapy Effective in Targeting Metastatic Cancer 2Health News:Military College to Set Up Stem Cell Research Centre 2
(Date:11/25/2009)...ire/--Reportlinker.comannouncesthatanewmarketresea...nagement-GlobalTrends ,, http://www.reportli...html ,, Widespreadavailabilityofgenericdrugs,e...rugshaveacceleratedthepaceofgrowthinthepainmanagem...recontinuetoshapedemandforservices,drugsanddevices...
(Date:11/25/2009)...NEY,Nov.25/PRNewswire-FirstCall/--HeartWareInterna...orandprovideroflessinvasive,miniaturizedcirculator...dvancedheartfailure,todayannouncedthatitisschedule...affrayHealthCareConferenceat8:00amESTonWednesday,D...PalaceHotel,December1-2. ,, AlivewebcastoftheCo...
(Date:11/24/2009)...wswire/-- ,, WHAT:RomHoubens,aBelgianmanthought...wasactuallyfullyconsciousandawakeduringthattimeand...oxEyeMaxwasfeaturedinthesegmenttoillustratehowpeop...communication. ,, WHEN:GoodMorningAmerica-- Tue...ch.com ,, WHO:RomHoubenswasanengineeringstu...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 1InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 2InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 3InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 4InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 5InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 6InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 7InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 8InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 9InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 10InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 11InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 12InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 13InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 14InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 15OncoGenex Reports Second Quarter 2009 Financial Results 13426 1OncoGenex Reports Second Quarter 2009 Financial Results 13426 2OncoGenex Reports Second Quarter 2009 Financial Results 13426 3OncoGenex Reports Second Quarter 2009 Financial Results 13426 4OncoGenex Reports Second Quarter 2009 Financial Results 13426 5OncoGenex Reports Second Quarter 2009 Financial Results 13426 6OncoGenex Reports Second Quarter 2009 Financial Results 13426 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 8
OCUFLOX® 5 mL
ALPHAGAN® 5 mL
ACULAR® 5 mL
ACULAR® 10 mL
Medicine Products: